NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: FORTIS · data 2026-10-30
Fortis Healthcare Ltd.
In plain words
Price: 26.2% below its 52-week high of ₹1,040.5.
Delivery: 55.6% of traded shares were kept for delivery over the last 10 sessions, against 54.3% over the last 60.
Latest results: a net profit of ₹266 cr for the quarter ended Jun 2026 (+2.3% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹9,506 cr |
| Net profit (last 12 months) | ₹1,048 cr |
| Sales growth, 3 years (yearly) | 13.4% |
| Profit growth, 3 years (yearly) | 21.0% |
Latest results in brief (Q1 FY27)
FORTIS Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹2,545.03 crore, up 17.5% YoY and up 7.6% QoQ.
Net profit was ₹266.39 crore, up 2.3% YoY and up 0.2% QoQ.
Operating margin was 21.1% (22.6% a year ago).
EPS was ₹3.53, up 2.3% YoY and up 0.3% QoQ.
FORTIS के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹2,545.03 करोड़; पिछले साल की तुलना में 17.5% की बढ़त, पिछली तिमाही की तुलना में 7.6% की बढ़त।
शुद्ध मुनाफ़ा: ₹266.39 करोड़; पिछले साल की तुलना में 2.3% की बढ़त, पिछली तिमाही की तुलना में 0.2% की बढ़त।
ऑपरेटिंग मार्जिन: 21.1% (एक साल पहले 22.6%)।
EPS: ₹3.53; पिछले साल की तुलना में 2.3% की बढ़त, पिछली तिमाही की तुलना में 0.3% की बढ़त।
FORTISના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹2,545.03 કરોડ; ગયા વર્ષની સરખામણીએ 17.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 7.6% વધારો.
ચોખ્ખો નફો: ₹266.39 કરોડ; ગયા વર્ષની સરખામણીએ 2.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 0.2% વધારો.
ઓપરેટિંગ માર્જિન: 21.1% (એક વર્ષ પહેલાં 22.6%).
EPS: ₹3.53; ગયા વર્ષની સરખામણીએ 2.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 0.3% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
28/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 10/30: Delivery 52.0% over the last 20 sessions vs 54.4% in the 40 before (0.96x); shares delivered per day 1.21x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 13/15: 44 schemes hold it, about ₹3,002 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend
- 6 Aug 26Results Q1 FY27 results: profit +2.3% YoY +3.3% next session
- 24 Jul 26Dividend Dividend ₹1 (ex-date) -0.1% next session
- 22 May 26Results Q4 FY26 results: profit +44.6% YoY +0.3% next session
- 13 Feb 26Results Q3 FY26 results: profit −21.9% YoY -1.4% next session
- 11 Nov 25Results Q2 FY26 results: profit +83.1% YoY -2.3% next session
- 6 Aug 25Results Q1 FY26 results: profit +57.0% YoY +1.9% next session
- 25 Jul 25Dividend Dividend ₹1 (ex-date) 0.0% next session
- 20 May 25Results Q4 FY25 results: profit +2.9% YoY -2.0% next session
- 7 Feb 25Results Q3 FY25 results: profit +84.1% YoY -3.7% next session
- 8 Nov 24Results Q2 FY25 results: profit +1.2% YoY +0.1% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹2,545 cr | ₹266 cr | +2.3% | 21.1% | 3.53 |
| Mar 2026 | ₹2,365 cr | ₹266 cr | +44.6% | 22.5% | 3.52 |
| Dec 2025 | ₹2,265 cr | ₹194 cr | -21.9% | 22.3% | 2.57 |
| Sept 2025 | ₹2,331 cr | ₹322 cr | +83.1% | 23.9% | 4.26 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% |
| Foreign institutions (FII) | 23.19% | 25.20% | 25.97% | 27.84% |
| Domestic institutions (DII) | 34.46% | 32.23% | 31.35% | 29.33% |
| Mutual funds | 26.94% | 25.81% | 25.72% | 24.22% |
| Retail investors | 3.23% | 3.27% | 3.35% | 3.47% |
| Number of shareholders | 2,17,704 | 2,20,743 | 2,26,685 | 2,33,156 |
Common questions
What was Fortis Healthcare Ltd.'s latest quarterly profit?
Fortis Healthcare Ltd. reported a net profit of ₹266 cr for the quarter ended Jun 2026 (+2.3% on the same quarter a year earlier), on revenue of ₹2,545 cr.
How much do promoters hold in Fortis Healthcare Ltd.?
Promoters held 31.17% of Fortis Healthcare Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Fortis Healthcare Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.35.
What is Fortis Healthcare Ltd.'s P/E ratio?
About 55.3, based on the last 12 months' earnings and a price of ₹768.15 (data 2026-10-30).
What is the 52-week high and low of Fortis Healthcare Ltd.?
The 52-week high is ₹1,040.5 and the 52-week low is ₹704.95.
Mutual funds holding Fortis Healthcare Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 44 schemes holding about ₹3,002 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Nippon India Growth Mid Cap Fund | Nippon India Mutual Fund | 2.53% | ₹1,270 cr |
| ADITYA BIRLA SUN LIFE ELSS TAX SAVER FUND | Aditya Birla Sun Life Mutual Fund | 1.70% | ₹231 cr |
| SBI Midcap Fund | SBI Mutual Fund | 0.84% | ₹196 cr |
| SBI Healthcare Opportunities Fund | SBI Mutual Fund | 2.36% | ₹139 cr |
| SBI Dividend Yield Fund | SBI Mutual Fund | 1.44% | ₹116 cr |
| NIPPON INDIA PHARMA FUND | Nippon India Mutual Fund | 1.13% | ₹104 cr |
| Mirae Asset Healthcare Fund | Mirae Asset Mutual Fund | 2.94% | ₹103 cr |
| Nippon India Vision Large & Mid Cap Fund | Nippon India Mutual Fund | 1.37% | ₹102 cr |
| ADITYA BIRLA SUN LIFE MIDCAP FUND | Aditya Birla Sun Life Mutual Fund | 1.38% | ₹90 cr |
| ADITYA BIRLA SUN LIFE MULTI-CAP FUND | Aditya Birla Sun Life Mutual Fund | 1.01% | ₹73 cr |
| NIPPON INDIA VALUE FUND | Nippon India Mutual Fund | 0.86% | ₹73 cr |
| SBI MNC Fund | SBI Mutual Fund | 1.09% | ₹70 cr |
| ADITYA BIRLA SUN LIFE LARGE & MID CAP FUND | Aditya Birla Sun Life Mutual Fund | 1.16% | ₹65 cr |
| ADITYA BIRLA SUN LIFE SMALL CAP FUND | Aditya Birla Sun Life Mutual Fund | 0.75% | ₹46 cr |
| SBI Infrastructure Fund | SBI Mutual Fund | 0.89% | ₹42 cr |
Similar companies
Manipal Health Enterprises Limited (MANIPALHOS) · Max Healthcare Institute Ltd (MAXHEALTH) · Aster DM Quality Care Limited (ASTERDM) · Narayana Hrudayalaya Ltd. (NH) · Global Health Limited (MEDANTA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open FORTIS in NSE Scanner →